125 related articles for article (PubMed ID: 21912141)
1. Association of p.His38Leu, a rare CYP21A2 mutation, with the classical simple virilizing phenotype of 21-hydroxylase deficiency in a 6-year-old boy.
Oriola J; Bosch MZ; Valls C; Ibáñez L
Horm Res Paediatr; 2011; 76(3):214-7. PubMed ID: 21912141
[TBL] [Abstract][Full Text] [Related]
2. Three novel CYP21A2 mutations and their protein modelling in patients with classical 21-hydroxylase deficiency from northeastern Iran.
Baradaran-Heravi A; Vakili R; Robins T; Carlsson J; Ghaemi N; A'rabi A; Abbaszadegan MR
Clin Endocrinol (Oxf); 2007 Sep; 67(3):335-41. PubMed ID: 17573904
[TBL] [Abstract][Full Text] [Related]
3. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetic analysis in 93 patients and 193 family members with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Croatia.
Dumic KK; Grubic Z; Yuen T; Wilson RC; Kusec V; Barisic I; Stingl K; Sansovic I; Skrabic V; Dumic M; New MI
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):51-56. PubMed ID: 27041116
[TBL] [Abstract][Full Text] [Related]
5. Substitutions in the CYP21A2 promoter explain the simple-virilizing form of 21-hydroxylase deficiency in patients harbouring a P30L mutation.
Araujo RS; Billerbeck AE; Madureira G; Mendonca BB; Bachega TA
Clin Endocrinol (Oxf); 2005 Feb; 62(2):132-6. PubMed ID: 15670187
[TBL] [Abstract][Full Text] [Related]
6. A new CYP21A2 nonsense mutation causing severe 21-hydroxylase deficiency.
Concolino P; Minucci A; Mello E; Zuppi C; Capoluongo E
Clin Chem Lab Med; 2009; 47(7):824-5. PubMed ID: 19499972
[TBL] [Abstract][Full Text] [Related]
7. Variations in the promoter of CYP21A2 gene identified in a Chinese patient with simple virilizing form of 21-hydroxylase deficiency.
Zhang HJ; Yang J; Zhang MN; Zhang W; Liu JM; Wang WQ; Ning G; Li XY
Clin Endocrinol (Oxf); 2009 Feb; 70(2):201-7. PubMed ID: 18702679
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of CYP21A2 gene mutations in two families with 21-hydroxylase deficiency].
Zheng R; Zhao Z; Wang Y; Yuan H; Wang S; Su Y; Ma Y; Hu Z; Tian R; Wang L
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Jun; 31(3):289-93. PubMed ID: 24928004
[TBL] [Abstract][Full Text] [Related]
9. p.H282N and p.Y191H: 2 novel CYP21A2 mutations in Italian congenital adrenal hyperplasia patients.
Concolino P; Mello E; Patrosso MC; Penco S; Zuppi C; Capoluongo E
Metabolism; 2012 Apr; 61(4):519-24. PubMed ID: 22014889
[TBL] [Abstract][Full Text] [Related]
10. Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: an update of new CYP21A2 mutations.
Concolino P; Mello E; Zuppi C; Capoluongo E
Clin Chem Lab Med; 2010 Aug; 48(8):1057-62. PubMed ID: 20482300
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic challenges in a patient with the simple virilizing (SV) form of congenital adrenal hyperplasia (CAH) due to the P30L/I172N genotype.
Tankoska M; Anastasovska V; Krstevska-Konstantinova M; Naydenov M; Kocova M
J Pediatr Endocrinol Metab; 2019 May; 32(5):543-547. PubMed ID: 31026224
[TBL] [Abstract][Full Text] [Related]
12. A rare CYP 21 mutation (p.E431K) induced deactivation of CYP 21A2 and resulted in congenital adrenal hyperplasia.
Kawashima Y; Usui T; Fujimoto M; Miyahara N; Nishimura R; Hanaki K; Kanzaki S
Endocr J; 2015; 62(1):101-6. PubMed ID: 25319875
[TBL] [Abstract][Full Text] [Related]
13. Identification and functional characterization of a novel mutation P459H and a rare mutation R483W in the CYP21A2 gene in two Chinese patients with simple virilizing form of congenital adrenal hyperplasia.
Jiang L; Song LL; Wang H; Wang JL; Wang PP; Zhou HB; Zhang XL
J Endocrinol Invest; 2012 May; 35(5):485-9. PubMed ID: 21750395
[TBL] [Abstract][Full Text] [Related]
14. Steroid 21-hydroxylase gene mutational spectrum in 454 Argentinean patients: genotype-phenotype correlation in a large cohort of patients with congenital adrenal hyperplasia.
Marino R; Ramirez P; Galeano J; Perez Garrido N; Rocco C; Ciaccio M; Warman DM; Guercio G; Chaler E; Maceiras M; Bergadá I; Gryngarten M; Balbi V; Pardes E; Rivarola MA; Belgorosky A
Clin Endocrinol (Oxf); 2011 Oct; 75(4):427-35. PubMed ID: 21609351
[TBL] [Abstract][Full Text] [Related]
15. Clinical phenotype and mutation spectrum of the CYP21A2 gene in patients with steroid 21-hydroxylase deficiency.
Choi JH; Jin HY; Lee BH; Ko JM; Lee JJ; Kim GH; Jung CW; Lee J; Yoo HW
Exp Clin Endocrinol Diabetes; 2012 Jan; 120(1):23-7. PubMed ID: 22020670
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization of two novel point mutations in the CYP21 gene causing simple virilizing forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Krone N; Riepe FG; Grötzinger J; Partsch CJ; Sippell WG
J Clin Endocrinol Metab; 2005 Jan; 90(1):445-54. PubMed ID: 15483094
[TBL] [Abstract][Full Text] [Related]
17. Investigation of CYP21A2 mutations in Turkish patients with 21-hydroxylase deficiency and a novel founder mutation.
Toraman B; Ökten A; Kalay E; Karagüzel G; Dinçer T; Açıkgöz EG; Karagüzel A
Gene; 2013 Jan; 513(1):202-8. PubMed ID: 23142378
[TBL] [Abstract][Full Text] [Related]
18. Functional and structural analysis of four novel mutations of CYP21A2 gene in Italian patients with 21-hydroxylase deficiency.
Massimi A; Malaponti M; Federici L; Vinciguerra D; Manca Bitti ML; Vottero A; Ghizzoni L; Maccarrone M; Cappa M; Bernardini S; Porzio O
Horm Metab Res; 2014 Jun; 46(7):515-20. PubMed ID: 24799024
[TBL] [Abstract][Full Text] [Related]
19. Molecular defects of the CYP21A2 gene in Greek-Cypriot patients with congenital adrenal hyperplasia.
Skordis N; Kyriakou A; Tardy V; Ioannou YS; Varvaresou A; Dracopoulou-Vabouli M; Patsalis PC; Shammas C; Neocleous V; Phylactou LA
Horm Res Paediatr; 2011; 75(3):180-6. PubMed ID: 20838032
[TBL] [Abstract][Full Text] [Related]
20. Microconversion between CYP21A2 and CYP21A1P promoter regions causes the nonclassical form of 21-hydroxylase deficiency.
Araújo RS; Mendonca BB; Barbosa AS; Lin CJ; Marcondes JA; Billerbeck AE; Bachega TA
J Clin Endocrinol Metab; 2007 Oct; 92(10):4028-34. PubMed ID: 17666484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
